effectiveness of personalized therapy in elderly patients with isolated systolic hypertension

Clicks: 152
ID: 129588
2015
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #20 of 30 articles by views in ieee international conference on microelectronic test structures

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The purpose of this study was the development of personalized modes of therapy in elderly patients with isolated systolic hypertension (ISH). The study included 306 persons divided into two groups: Group 1(Control) included 150 elderly persons without arterial hypertension (AH), and Group 2 included 256 elderly patients (early old-age pension, between 65 and 74 years) with ISH (ESH/ESC,2013) according to the inclusion/exclusion criteria. All patients of Group 2 were divided into three subgroups depending on the combination of drugs at the beginning of the study. Group 2a (n=53) received amlodipine (5mg/day) and indapamide-retard (1.5 mg/day), Group 2b (n=53) received valsartan (80 mg/day) and indapamide-retard (1.5 vg/day), and Group2c (n=50) received amlodipine (5 mg/day) and valsartan (80 mg/day). The duration of therapy was 5.2 years. At the stage of data collection and screening, we applied standard methods for identification of ISH and secondary hypertension. Molecular phenotyping of blood serum was performed with methods of proteomics. We obtained the data of the molecular interactions and functional features of proteins from the STRING 10.0 database. Proteomic analysis contributes to the development of a personalized mode treatment in ISH patients, which is the safest and most efficient: 135 ISH patients switched to the administration of the amlodipine+valsartan combination.
Reference Key
sarvilina2015internationaleffectiveness Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Irina V. Sarvilina
Journal ieee international conference on microelectronic test structures
Year 2015
DOI
DOI not found
URL
http://ijbm.org/articles/Article5(4)_OA7.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.